This is an open study for all centers in the European-Dementia of Lewy body consortium. This study involves collection of clinical data and biomarker collection to be used for central analysis. The aim is to explore and validate diagnostic and prognostic biomarkers for Lewy body dementia. Studies involving role and features of imaging biomarkers (MRI, FDG PET and DAT SPECT) in DLB patients have been carried out so far in the E-DLB. As well as EEG analysis and bio fluid recollection. Standard Operating Procedures for MRI, SPECT, PET-FDG and EEG are available for all E-DLB members.
